← Open Payments lookup

ELIZABETH WILLENS: Open Payments

NPI 1649965633 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$790 in 52 payments from 13 companies in 2025. Trend: 2023 $699 · 2024 $866 · 2025 $790

Food & beverage: $783Education: $8
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.16$176
ABBVIE INC.14$172
Otsuka America Pharmaceutical, Inc.5$93
Alkermes, Inc.3$70
E.R. Squibb & Sons, L.L.C.3$62
Vanda Pharmaceuticals Inc.2$44
Teva Pharmaceuticals USA, Inc.2$33
Axsome Therapeutics, Inc.2$29
Neurocrine BioSciences, Inc.1$25
Lundbeck LLC1$25

Products named: VRAYLAR, Qelbree, REXULTI, COBENFY, ARISTADA, HETLIOZ, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across KS — which companies pay providers there.